DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 17 2024
0mins
Source: PRnewswire
- Investigation by Faruqi & Faruqi, LLP: The law firm is investigating potential claims against agilon health, inc. and reminds investors of the May 20, 2024 deadline to seek the role of lead plaintiff in a federal securities class action.
- Allegations Against Agilon: The complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements about medical costs, business model effectiveness, financial guidance, and risk disclosures.
- Revelation of Higher Medical Costs: Agilon faced increased medical costs which were revealed on November 2, 2023, leading to a stock price drop. Further surprises in January 2024 included lowered profit forecasts and the CFO's retirement announcement.
- Lead Plaintiff Role: The court-appointed lead plaintiff oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff or remain an absent class member.
- Encouragement for Information Sharing: Faruqi & Faruqi, LLP encourages anyone with information regarding agilon's conduct to contact the firm, including whistleblowers, former employees, shareholders, and others.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on AGL
Wall Street analysts forecast AGL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AGL is 0.98 USD with a low forecast of 0.50 USD and a high forecast of 1.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
1 Buy
7 Hold
2 Sell
Hold
Current: 0.854
Low
0.50
Averages
0.98
High
1.50
Current: 0.854
Low
0.50
Averages
0.98
High
1.50
About AGL
agilon health, inc. is a healthcare company. It enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Faruqi & Faruqi Investigates Securities Fraud at agilon health
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential securities fraud claims against agilon health, focusing on investor losses incurred between February 26 and August 4, 2025, indicating significant legal risks for the company.
- Financial Guidance Missteps: The lawsuit alleges that agilon health executives recklessly issued guidance for 2025 that they knew was unattainable due to known industry headwinds, resulting in substantial investor losses and highlighting governance failures within the company.
- Stock Price Plunge: Following the announcement to suspend its 2025 financial guidance, agilon health's stock plummeted by 51.5% on August 5, 2025, reflecting severe market concerns regarding the company's financial health.
- Investor Rights Protection: Faruq & Faruqi encourages investors to be aware that March 2 is the deadline to apply as lead plaintiff in the class action, emphasizing the importance of protecting investor rights.
Continue Reading
Agilon Health Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Agilon Health (NYSE: AGL) securities between February 26 and August 4, 2025, to apply as lead plaintiffs by March 2, 2026, to participate in the class action and seek compensation.
- No Out-of-Pocket Costs: Investors joining the class action will incur no upfront fees, as the law firm operates on a contingency fee basis, thereby reducing the financial burden on investors.
- Lawsuit Background: The lawsuit alleges that Agilon Health made false and misleading statements during the class period, resulting in investor losses when the true situation became known, highlighting significant failures in the company's financial guidance and strategic actions.
- Law Firm's Credentials: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, demonstrating its expertise and resource advantages in handling such cases.
Continue Reading